Absence of MDR-1 P-glycoprotein at the blood-brain barrier increased the passage of blood-borne exogenous Aβ peptides across the BBB into the brain
Wandong Zhang,Huaqi Xiong,Shanshan Shen,Aimee Jones,Peilin Huang,Howard Njoo,Jun Wu
DOI: https://doi.org/10.1016/j.jalz.2010.05.1398
2010-01-01
Abstract:Alzheimer's disease (AD) is characterized by accumulation and deposition of Aβ peptides in the brain. Experimental studies showed that Aβ can be transported across blood-brain barrier (BBB). Aberrant Aβ transport across BBB may contribute to accumulation and deposition of Aβ in the brain. Some studies suggested that mis-folded Aβ can be transmitted via transfusion from donors to recipients, which may be a risk factor of AD pathogenesis. Several transporters/receptors are involved in Aβ transport across BBB. MDR-1 P-glycoprotein/ABCB1 (Pgp) is highly expressed in cerebroendothelial cells and acts as a major drug transporter at the BBB. Pgp was shown to play a substantial role in Aβ elimination from brain. However, it is unknown whether Pgp can prevent blood-borne exogenous Aβ from entering the brain. In the present study, we investigated the role of Pgp in the passage of blood-borne Aβ across the BBB into the brain. Cy5.5-labeled Aβ1-40 or Cy5.5 free-dye were injected intravenously into mdr-1a/b knockout (Pgp-null) and wild-type (wt) mice. The mice were scanned alive with a time-domain optical imager eXplore Optix at 2, 4, 6, and 8h post-injection for Cy5.5 fluorescence accumulation in the brain. Mice were sacrificed at 8h and their ex vivo brains were scanned. The concentration of Cy5.5 fluorescence in the heads of Pgp-null mice was higher at 4 time-points than that in wt mice injected with the same amount of Cy5.5-labeled Aβ1-40 (Pgp-null/wt mice: 2h: 124.61%/100%; 4h: 126.21%/100%; 6h: 116.03%/100%; 8h: 141.28%/100%). The fluorescent concentration in the ex vivo brain was also higher in Pgp-null mice (109.33%) than wt (100%). Two pairs of Pgp-null mice were injected with either Cy5.5-labeled Aβ peptides or Cy5.5 free-dye in equal fluorescent intensity and their ex vivo brains were scanned at 8h. The two Pgp-null mice injected with Cy5.5-labeled Aβ had about 1.5-fold higher fluorescence in their brains than the Pgp-null mice injected with Cy5.5 free-dye in equal fluorescent intensity, suggesting that Cy5.5-labeled Aβ peptides easily trans-passed BBB into brain than Cy5.5 free-dye in Pgp-null mice. These results indicate that the absence of Pgp at the BBB increased the passage of blood-borne exogenous Aβ across the BBB into the brain.
What problem does this paper attempt to address?